HEADER OXIDOREDUCTASE 17-FEB-20 6VVB TITLE MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE IN COMPLEX WITH 6- TITLE 2 METHYL-5-(4-PHENYLTHIAZOL-2-YL)-2- (TRIFLUOROMETHYL)NICOTINIC ACID TITLE 3 (FRAGMENT 10) COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS (STRAIN ATCC 25618 / SOURCE 3 H37RV); SOURCE 4 ORGANISM_TAXID: 83332; SOURCE 5 STRAIN: ATCC 25618 / H37RV; SOURCE 6 GENE: FOLA, DFRA, RV2763C, MTV002.28C; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS FOLATE PATHWAY, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR P.TYRAKIS,M.V.B.DIAS REVDAT 3 11-OCT-23 6VVB 1 REMARK REVDAT 2 26-AUG-20 6VVB 1 JRNL REVDAT 1 15-JUL-20 6VVB 0 JRNL AUTH J.A.RIBEIRO,A.HAMMER,G.A.LIBREROS-ZUNIGA,S.M.CHAVEZ-PACHECO, JRNL AUTH 2 P.TYRAKIS,G.S.DE OLIVEIRA,T.KIRKMAN,J.EL BAKALI,S.A.ROCCO, JRNL AUTH 3 M.L.SFORCA,R.PARISE-FILHO,A.G.COYNE,T.L.BLUNDELL,C.ABELL, JRNL AUTH 4 M.V.B.DIAS JRNL TITL USING A FRAGMENT-BASED APPROACH TO IDENTIFY ALTERNATIVE JRNL TITL 2 CHEMICAL SCAFFOLDS TARGETING DIHYDROFOLATE REDUCTASE JRNL TITL 3 FROMMYCOBACTERIUM TUBERCULOSIS. JRNL REF ACS INFECT DIS. V. 6 2192 2020 JRNL REFN ESSN 2373-8227 JRNL PMID 32603583 JRNL DOI 10.1021/ACSINFECDIS.0C00263 REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.62 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.130 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.0 REMARK 3 NUMBER OF REFLECTIONS : 27830 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.149 REMARK 3 R VALUE (WORKING SET) : 0.147 REMARK 3 FREE R VALUE : 0.180 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1388 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.6160 - 3.1226 0.86 2638 132 0.1530 0.1826 REMARK 3 2 3.1226 - 2.4790 0.91 2759 144 0.1644 0.1787 REMARK 3 3 2.4790 - 2.1658 0.88 2635 138 0.1455 0.1839 REMARK 3 4 2.1658 - 1.9678 0.90 2711 148 0.1308 0.1618 REMARK 3 5 1.9678 - 1.8268 0.73 2169 108 0.1275 0.1728 REMARK 3 6 1.8268 - 1.7191 0.89 2678 141 0.1286 0.1810 REMARK 3 7 1.7191 - 1.6330 0.99 2963 174 0.1354 0.1610 REMARK 3 8 1.6330 - 1.5620 0.99 2948 159 0.1357 0.1840 REMARK 3 9 1.5620 - 1.5018 0.83 2515 115 0.1519 0.2054 REMARK 3 10 1.5018 - 1.4500 0.81 2426 129 0.1661 0.2224 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.100 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.550 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6VVB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-FEB-20. REMARK 100 THE DEPOSITION ID IS D_1000247141. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27836 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 31.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.1 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.47 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 0.50600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1DF7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% PEG 4000, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 33.93000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.86500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 33.93000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.86500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 423 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 431 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 0 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 HIS A 38 O HOH A 301 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG SER A 74 O HOH A 338 2656 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 21 32.13 -83.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue RQ4 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P33 A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 203 DBREF 6VVB A -1 159 UNP P9WNX1 DYR_MYCTU 1 161 SEQRES 1 A 161 MET THR MET VAL GLY LEU ILE TRP ALA GLN ALA THR SER SEQRES 2 A 161 GLY VAL ILE GLY ARG GLY GLY ASP ILE PRO TRP ARG LEU SEQRES 3 A 161 PRO GLU ASP GLN ALA HIS PHE ARG GLU ILE THR MET GLY SEQRES 4 A 161 HIS THR ILE VAL MET GLY ARG ARG THR TRP ASP SER LEU SEQRES 5 A 161 PRO ALA LYS VAL ARG PRO LEU PRO GLY ARG ARG ASN VAL SEQRES 6 A 161 VAL LEU SER ARG GLN ALA ASP PHE MET ALA SER GLY ALA SEQRES 7 A 161 GLU VAL VAL GLY SER LEU GLU GLU ALA LEU THR SER PRO SEQRES 8 A 161 GLU THR TRP VAL ILE GLY GLY GLY GLN VAL TYR ALA LEU SEQRES 9 A 161 ALA LEU PRO TYR ALA THR ARG CYS GLU VAL THR GLU VAL SEQRES 10 A 161 ASP ILE GLY LEU PRO ARG GLU ALA GLY ASP ALA LEU ALA SEQRES 11 A 161 PRO VAL LEU ASP GLU THR TRP ARG GLY GLU THR GLY GLU SEQRES 12 A 161 TRP ARG PHE SER ARG SER GLY LEU ARG TYR ARG LEU TYR SEQRES 13 A 161 SER TYR HIS ARG SER HET RQ4 A 201 25 HET P33 A 202 22 HET NAP A 203 48 HETNAM RQ4 6-METHYL-5-(4-PHENYL-1,3-THIAZOL-2-YL)-2- HETNAM 2 RQ4 (TRIFLUOROMETHYL)PYRIDINE-3-CARBOXYLIC ACID HETNAM P33 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETSYN P33 HEPTAETHYLENE GLYCOL; PEG330 HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 RQ4 C17 H11 F3 N2 O2 S FORMUL 3 P33 C14 H30 O8 FORMUL 4 NAP C21 H28 N7 O17 P3 FORMUL 5 HOH *154(H2 O) HELIX 1 AA1 LEU A 24 GLU A 26 5 3 HELIX 2 AA2 ASP A 27 MET A 36 1 10 HELIX 3 AA3 ARG A 44 LEU A 50 1 7 HELIX 4 AA4 PRO A 51 ARG A 55 5 5 HELIX 5 AA5 SER A 81 LEU A 86 1 6 HELIX 6 AA6 GLY A 96 LEU A 104 1 9 HELIX 7 AA7 PRO A 105 ALA A 107 5 3 SHEET 1 AA1 8 GLU A 77 VAL A 79 0 SHEET 2 AA1 8 ARG A 61 LEU A 65 1 N VAL A 64 O GLU A 77 SHEET 3 AA1 8 THR A 39 GLY A 43 1 N ILE A 40 O ARG A 61 SHEET 4 AA1 8 GLU A 90 VAL A 93 1 O TRP A 92 N THR A 39 SHEET 5 AA1 8 MET A 1 ALA A 9 1 N GLY A 3 O VAL A 93 SHEET 6 AA1 8 ARG A 109 VAL A 115 1 O VAL A 115 N GLN A 8 SHEET 7 AA1 8 ARG A 150 HIS A 157 -1 O TYR A 154 N VAL A 112 SHEET 8 AA1 8 ARG A 136 THR A 139 -1 N ARG A 136 O HIS A 157 SHEET 1 AA2 8 GLU A 77 VAL A 79 0 SHEET 2 AA2 8 ARG A 61 LEU A 65 1 N VAL A 64 O GLU A 77 SHEET 3 AA2 8 THR A 39 GLY A 43 1 N ILE A 40 O ARG A 61 SHEET 4 AA2 8 GLU A 90 VAL A 93 1 O TRP A 92 N THR A 39 SHEET 5 AA2 8 MET A 1 ALA A 9 1 N GLY A 3 O VAL A 93 SHEET 6 AA2 8 ARG A 109 VAL A 115 1 O VAL A 115 N GLN A 8 SHEET 7 AA2 8 ARG A 150 HIS A 157 -1 O TYR A 154 N VAL A 112 SHEET 8 AA2 8 ARG A 143 PHE A 144 -1 N ARG A 143 O TYR A 151 SHEET 1 AA3 2 VAL A 13 GLY A 15 0 SHEET 2 AA3 2 ALA A 126 LEU A 127 -1 O ALA A 126 N ILE A 14 CISPEP 1 ARG A 55 PRO A 56 0 4.81 CISPEP 2 GLY A 95 GLY A 96 0 0.77 SITE 1 AC1 9 GLN A 28 PHE A 31 ARG A 32 LEU A 50 SITE 2 AC1 9 LYS A 53 VAL A 54 LEU A 57 ARG A 60 SITE 3 AC1 9 NAP A 203 SITE 1 AC2 6 THR A 10 SER A 11 GLY A 12 ARG A 121 SITE 2 AC2 6 ALA A 128 VAL A 130 SITE 1 AC3 37 TRP A 6 ALA A 7 ILE A 14 GLY A 15 SITE 2 AC3 37 ARG A 16 GLY A 18 ASP A 19 ILE A 20 SITE 3 AC3 37 GLY A 43 ARG A 44 ARG A 45 THR A 46 SITE 4 AC3 37 LEU A 65 SER A 66 ARG A 67 GLN A 68 SITE 5 AC3 37 GLY A 80 ILE A 94 GLY A 95 GLY A 96 SITE 6 AC3 37 GLY A 97 GLN A 98 VAL A 99 TYR A 100 SITE 7 AC3 37 LEU A 102 ARG A 136 HIS A 157 RQ4 A 201 SITE 8 AC3 37 HOH A 318 HOH A 325 HOH A 332 HOH A 345 SITE 9 AC3 37 HOH A 354 HOH A 369 HOH A 372 HOH A 382 SITE 10 AC3 37 HOH A 384 CRYST1 67.860 73.730 36.780 90.00 99.89 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014736 0.000000 0.002569 0.00000 SCALE2 0.000000 0.013563 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027599 0.00000